A python molecule that made obese mice eat less

Date:

Share post:

Why pythons are a metabolism outlier

Burmese pythons can swallow prey close to their own body weight, then go months and sometimes much longer without eating again. After a meal, their physiology shifts dramatically: metabolism surges and even the heart temporarily enlarges as digestion ramps up. Researchers say that extreme swing makes pythons a useful model for finding molecules that influence appetite and energy balance.

The discovery: a post meal blood spike

Scientists studying young Burmese pythons analyzed blood samples taken before feeding and then within hours after a large meal. They found more than 200 molecules that rose significantly after eating. One stood out, increasing more than 1,000 fold. The molecule is called pTOS and appears to be produced by gut bacteria.

Researchers also note pTOS is not exclusive to snakes. It has been detected at low levels in human urine, which matters because it suggests the compound is already part of human biology, even if usually at very small concentrations.

What happened in mice

When the team gave pTOS to laboratory mice, they did not see obvious changes in organ size or overall energy expenditure. The major effect showed up in behavior. Obese mice that received pTOS ate less than control mice, and after 28 days had lost about 9% of body weight.

How it may differ from Wegovy style drugs

GLP-1 medications like semaglutide can reduce appetite, but they also work partly by slowing stomach emptying, which is linked to side effects such as nausea, constipation, and stomach discomfort. In this research, pTOS appears to influence appetite through the brain, acting on the hypothalamus, a region known to regulate hunger and feeding.

The researchers describe this as a potentially different mechanism from GLP-1 drugs, which raises the possibility of a future weight loss therapy that could complement existing options, or help patients who cannot tolerate current treatments.

What this could mean next

The authors say the findings are early and not yet ready for clinical use. More work is needed to confirm safety, understand dosing, and verify whether the appetite effects translate beyond mice. Still, the result highlights a broader idea: studying animals with extreme adaptations can reveal new metabolic pathways that might be leveraged for human medicine.

Related articles

Carl Pei says the future phone may not need apps

A bold claim from the Nothing CEO Carl Pei, co-founder and CEO of Nothing, says the next major shift...

After Ozempic, People Keep Some Weight Off, but the “What” Matters

A new estimate: some weight loss may persist after stopping A new analysis suggests that people who stop taking...

Americans Turn to AI for Financial Advice, but Experts Warn Against Overreliance

AI is becoming a go-to money tool More Americans are using artificial intelligence to help manage their personal finances,...

Uber and NVIDIA Plan Robotaxi Expansion to 28 Cities by 2028

Launch begins in Los Angeles and San Francisco in 2027 Uber Technologies and NVIDIA announced an expanded autonomous vehicle...